|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 49, 147-152, January 2008
Copyright © 2008 by American Society for Biochemistry and Molecular Biology


* Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Departments of Medicine (Division of Neurology) and Physiology, Centre for Research in Neurodegenerative Diseases, University of Toronto, Ontario, Canada
Published, JLR Papers in Press, October 11, 2007.
1 Current address of D. W. L. Ma: Department of Human Health and Nutritional Sciences, College of Biological Science, University of Guelph, Guelph, Ontario, Canada.
2 To whom correspondence should be addressed. e-mail: richard.bazinet{at}utoronto.ca
The brain cannot synthesize n-6 or n-3 PUFAs de novo and requires their transport from the blood. Two models of brain fatty acid uptake have been proposed. One requires the passive diffusion of unesterified fatty acids through endothelial cells of the blood-brain barrier, and the other requires the uptake of lipoproteins via a lipoprotein receptor on the luminal membrane of endothelial cells. This study tested whether the low density lipoprotein receptor (LDLr) is necessary for maintaining brain PUFA concentrations. Because the cortex has a low basal expression of LDLr and the anterior brain stem has a relatively high expression, we analyzed these regions separately. LDLr knockout (LDLr–/–) and wild-type mice consumed an AIN-93G diet ad libitum until 7 weeks of age. After microwaving, the cortex and anterior brain stem (pons and medulla) were isolated for phospholipid fatty acid analyses. There were no differences in phosphatidylserine, phosphatidylinositol, ethanolamine, or choline glycerophospholipid esterified PUFA or saturated or monounsaturated fatty acid concentrations in the cortex or brain stem between LDLr–/– and wild-type mice. These findings demonstrate that the LDLr is not necessary for maintaining brain PUFA concentrations and suggest that other mechanisms to transport PUFAs into the brain must exist.
Supplementary key words arachidonic acid docosahexaenoic acid transport knockout
Abbreviations: 16:0, palmitic acid; 18:2n-6, linoleic acid; 18:3n-3,
-linolenic acid; 20:4n-6, arachidonic acid; 22:6n-3, docosahexaenoic acid; CerPCho, sphingomyelin; ChoGpl, choline glycerophospholipid; EtnGpl, ethanolamine glycerophospholipid; LDLr, low density lipoprotein receptor; PtdIns, phosphatidylinositol; PtdSer, phosphatidylserine
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Igarashi, K. Ma, L. Chang, J. M. Bell, and S. I. Rapoport Rat heart cannot synthesize docosahexaenoic acid from circulating {alpha}-linolenic acid because it lacks elongase-2 J. Lipid Res., August 1, 2008; 49(8): 1735 - 1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Green, S. K. Orr, and R. P. Bazinet The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids J. Lipid Res., May 1, 2008; 49(5): 939 - 944. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |